SCHEMBL856772

SCHEMBL856772

Cc1ccc2ncnc(N3CCOc4ccc(-c5cnc6[nH]c(NC(=O)OCc7ccccc7)nc6c5)cc4C3)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.38
PDGFRB P09619 1/20 0.37
RAF1 P04049 1/20 0.37
BRAF P15056 1/20 0.37
FYN P06241 1/20 0.36
PRMT5 O14744 3/20 0.35
CREBBP Q92793 1/20 0.34
CLK4 Q9HAZ1 4/20 0.34
MTOR P42345 1/20 0.34
MAPK1 P28482 3/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
CYP2C19 P33261 2/20 0.34
HIF1A Q16665 2/20 0.34
LMNA P02545 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6126132 0.89 PIK3CA (0.40) PIK3CAPDGFRBCREBBPCLK4MTOR
SCHEMBL3757572 0.84 PIK3CA (0.39) PIK3CAPDGFRBCREBBPCLK4MTOR
SCHEMBL856147 0.80 CYP3A4 (0.41) PIK3CACLK4MAPK1ALDH1A1TSHR
SCHEMBL7858604 0.77 LMNA (0.47) PIK3CARAF1BRAFCREBBPCLK4
SCHEMBL856773 0.77 PIK3CA (0.40) PIK3CAPDGFRBCREBBPCLK4MTOR
SCHEMBL3716268 0.76 PIK3CA (0.42) PIK3CACREBBPCLK4MAPK1ALDH1A1
SCHEMBL3763910 0.75 PRMT5 (0.45) PIK3CAPRMT5CLK4MAPK1ALDH1A1
SCHEMBL3719872 0.75 CYP3A4 (0.42) CLK4MAPK1ALDH1A1TSHRCYP2C19
SCHEMBL856771 0.75 CREBBP (0.37) PIK3CAPDGFRBPRMT5CREBBPCLK4
SCHEMBL13056673 0.74 MTNR1B (0.44) PIK3CAPDGFRBCLK4MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed